HomePBIGF • OTCMKTS
add
Paradigm Biopharmaceuticals Ltd
Previous close
$0.38
Day range
$0.20 - $0.20
Year range
$0.11 - $0.38
Market cap
107.09M AUD
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 8.35K | — |
Operating expense | 3.17M | -87.35% |
Net income | -2.96M | 88.16% |
Net profit margin | -35.47K | — |
Earnings per share | — | — |
EBITDA | -3.14M | 87.47% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.78M | -26.15% |
Total assets | 35.36M | -21.50% |
Total liabilities | 1.30M | -88.42% |
Total equity | 34.06M | — |
Shares outstanding | 389.43M | — |
Price to book | 4.23 | — |
Return on assets | -22.44% | — |
Return on capital | -23.18% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -2.96M | 88.16% |
Cash from operations | -4.11M | 83.89% |
Cash from investing | 23.10K | 0.00% |
Cash from financing | 7.56M | -46.59% |
Net change in cash | 3.48M | 130.54% |
Free cash flow | -1.92M | 87.41% |
About
Founded
2014
Website
